Home | News | Events | Contact Us | English | 繁體中文 | 日本語
About Us Product & Service Facilities Quality & Compliance For Investors Career
Latest Events
Latest News
Product & Service
DCAT Week, New York
Mar. 20-23, 2023
BIO International Convention, Boston, MA
June. 5-8, 2023
Formosa Labs’ fermentation production line was successfully inspected by US FDA in November 2022. 2022-11-15
TW Patent No. I781345 entitled Crystalline form of Baricitinib and method for preparation thereof was granted on Oct 21, 2022. 2022-11-08
Formosa has won the Talent Quality-management System (TTQS) Bronze Medal Award. 2022-11-07
Formosa Injectable plant passed GMP/GDP inspection by TFDA.(Jun. 15, 2022) 2022-06-21
Formosa Pharmaceuticals and AimMax Therapeutics Announce Successful Top-Line Results from CPN-301 for the Treatment of Inflammation and Pain after Cataract Surgery 2022-05-13
Active Pharmaceutical Ingredients
Contract Development and Manufacturing Organization (CDMO)
Antibody Drug Conjugates (ADCs)
Injectable Manufacturing Services

Copyright ©2014 Formosa Laboratories, Inc. All Rights Reserved.